Want to see KMB full AI Analyst Report?
Revenue by Segment
Breaks down revenue from different business segments, showing which products or services are leading sales and where there might be potential for growth or decline.
Personal Care remains the clear revenue anchor with consistent organic momentum and market‑share gains, Consumer Tissue is steady, and K‑C Professional delivered stronger growth earlier but softened recently; the abrupt cessation of segment figures after late‑2024 points to reporting/reclassification tied to the Kenvue integration—confirm in filings. Management is relying on industry‑leading 6% productivity, pricing net of costs and a $2bn supply‑chain program to absorb a Q2 DC‑fire top‑line hit and potential H2 oil‑driven input costs, so execution risk — not end‑market demand — is the key near‑term vulnerability.
KMB Revenue by Segment
| Date | Corporate and Other | Personal Care | Consumer Tissue | K-C Professional |
|---|---|---|---|---|
| Jun 30, 2026 | $0.00 | $0.00 | $0.00 | $0.00 |
| Mar 31, 2026 | $0.00 | $0.00 | $0.00 | $0.00 |
| Dec 31, 2025 | $0.00 | $0.00 | $0.00 | $0.00 |
| Sep 30, 2025 | $0.00 | $0.00 | $0.00 | $0.00 |
| Jun 30, 2025 | $0.00 | $0.00 | $0.00 | $0.00 |
| Mar 31, 2025 | $0.00 | $0.00 | $0.00 | $0.00 |
| Dec 31, 2024 | $0.00 | $0.00 | $0.00 | $0.00 |
| Sep 30, 2024 | $11.00M | $2.63B | $1.54B | $767.00M |
| Jun 30, 2024 | $10.00M | $2.69B | $1.49B | $841.00M |
| Mar 31, 2024 | $14.00M | $2.71B | $1.60B | $823.00M |
| Dec 31, 2023 | $12.00M | $2.60B | $1.54B | $816.00M |
| Sep 30, 2023 | $11.00M | $2.70B | $1.57B | $854.00M |
| Jun 30, 2023 | $13.00M | $2.69B | $1.55B | $887.00M |
| Mar 31, 2023 | $10.00M | $2.70B | $1.63B | $847.00M |
| Dec 31, 2022 | $11.00M | $2.56B | $1.56B | $838.00M |
| Sep 30, 2022 | $11.00M | $2.63B | $1.58B | $836.00M |
| Jun 30, 2022 | $14.00M | $2.71B | $1.54B | $802.00M |
| Mar 31, 2022 | $18.00M | $2.73B | $1.57B | $780.00M |
| Dec 31, 2021 | $16.00M | $2.63B | $1.56B | $758.00M |
| Sep 30, 2021 | $16.00M | $2.66B | $1.54B | $797.00M |
| Jun 30, 2021 | $16.00M | $2.52B | $1.42B | $765.00M |
| Mar 31, 2021 | $19.00M | $2.46B | $1.51B | $752.00M |
| Dec 31, 2020 | $18.00M | $2.35B | $1.73B | $742.00M |
| Sep 30, 2020 | $16.00M | $2.34B | $1.62B | $705.00M |
| Jun 30, 2020 | $14.00M | $2.23B | $1.65B | $724.00M |
| Mar 31, 2020 | $16.00M | $2.42B | $1.72B | $848.00M |
| Dec 31, 2019 | $15.00M | $2.24B | $1.51B | $815.00M |
| Sep 30, 2019 | $12.00M | $2.31B | $1.48B | $839.00M |
| Jun 30, 2019 | $15.00M | $2.29B | $1.47B | $821.00M |
| Mar 31, 2019 | $15.00M | $2.27B | $1.53B | $817.00M |
| Dec 31, 2018 | $12.00M | $2.22B | $1.50B | $841.00M |
| Sep 30, 2018 | $13.00M | $2.25B | $1.47B | $848.00M |
| Jun 30, 2018 | $14.00M | $2.26B | $1.47B | $861.00M |
| Mar 31, 2018 | $13.00M | $2.31B | $1.58B | $832.00M |
